Information  X 
Enter a valid email address

Elsevier (REL)

  Print      Mail a friend       Annual reports

Friday 31 October, 2008


Elsevier is Expanding eClinical Solutions in Eu...

COPENHAGEN, Denmark, October 31 /PRNewswire/ --

    - DoctorConsult in Germany Marks First of Several Localized Workflow
Solutions That Improve Clinician Decision Making and Health Care Business

    With a deep understanding of healthcare workflow and more than
a century of experience as a global medical publisher, Elsevier is increasing
its efforts to provide interactive clinical reference and clinical decision
support (CDS) tools to new markets in Europe. With the launch of
DoctorConsult - the German language version of MD Consult ( -- Elsevier becomes the first multi-lingual
professional clinical reference product provider.

    The customized products meet the cultural needs of users who
do not speak English as a first language, and address specific medical
practice needs within different countries. The internet-based products
provide users with a full range of medical information covering a variety of
clinical needs. In one integrated interface, users can access evidence-based
immediately actionable 'quick answers' (i.e. Elsevier's FirstConsult) as well
as background references such as books and full text journal articles
suitable for more in depth research and education needs. Additional localized
versions of MD Consult are in development for Italy, France and Spain.

    The Consult suite of multilingual reference products is just
one of several solutions being developed to meet local reference,
point-of-care, workflow and decision support needs. Additional solutions in
development include:

    - Clinical Decision Support:

    - Guidelines and best practice information delivered when and where 
      they are most useful at the point of care

    - Leveraging of patient data to pinpoint the most needed information 
      for a given clinical task

    - Drug information and safety checking, also linked to patient data 
      when possible

    - Seamless content integration with Electronic Health Records, including 
      infobuttons and alerts

    - Payer services:

    - Retrospective analytics for identifying performance gaps and outliers

    - Tools to influence provider behavior (CDS solutions)

    "Elsevier has been transforming CDS technology to offer a
higher level of usability, primarily in the U.S. and now more so in Europe,"
said Jose Wehnes, Managing Director of the International Division of Elsevier
Health Sciences. "Elsevier knowledge solutions, from drug information and
actionable decision support, to process improvement and predictive analysis,
have the potential to help deliver timely and appropriate information to
clinicians in any country as they make critical diagnostic and therapeutic
decisions throughout their workday."

Capturing 'e' Opportunities

    Elsevier is uniquely positioned to replicate its success in
the U.S. abroad. Market dynamics are different, as European E-Health markets
and Elsevier's positions within them are at an earlier stage of development
than in the U.S. However, key underlying market forces are similar to those
in the U.S, particularly the drive to contain costs and improve outcomes, and
the rapid increase in internet usage by physicians and other healthcare

    "By building upon our core strengths in leading content to
provide information and workflow solutions, we can improve outcomes and
efficiencies for both payers and providers on a country by country basis,"
said Wehnes. "Growing Elsevier Clinical Decision Support in Europe reinforces
Elsevier's broader business strategy to strengthen its lead in core content,
drive the transition of print materials to e-formats and deliver solutions
directly into the clinical process."

    Come by booth #625 at the World of Health IT Conference in
Copenhagen, Denmark November 4-6, 2008 to learn more.

About Elsevier

    Elsevier is a world-leading publisher of scientific, technical
and medical information products and services. Working in partnership with
the global science and health communities, Elsevier's 7,000 employees in over
70 offices worldwide publish more than 2,000 journals and 1,900 new books per
year, in addition to offering a suite of innovative electronic products, such
as ScienceDirect (, MD Consult (, Mosby Nursing Consult ( Scopus (,
bibliographic databases and online reference works.

    Elsevier ( is a global business
headquartered in Amsterdam, The Netherlands and has offices worldwide.
Elsevier is part of Reed Elsevier Group plc (, a
world-leading publisher and information provider. Operating in the science
and medical, legal, education and business-to-business sectors, Reed Elsevier
provides high-quality and flexible information solutions to users, with
increasing emphasis on the Internet as a means of delivery. Reed Elsevier's
ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK
and ENL (New York Stock Exchange).

    Tom Reller
    Director of Corp. Relations, Elsevier
    [email protected]

a d v e r t i s e m e n t